{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:53:22Z","timestamp":1794970402293,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014M3A9D5A01073886"],"award-info":[{"award-number":["2014M3A9D5A01073886"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C3005801"],"award-info":[{"award-number":["2021R1A2C3005801"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HR14C0001"],"award-info":[{"award-number":["HR14C0001"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatic endoplasmic reticulum (ER) stress is implicated in the development of steatosis and its progression to nonalcoholic steatohepatitis (NASH). The ER in the liver can sustain metabolic function by activating defense mechanisms that delay or prevent the progression of nonalcoholic fatty liver disease (NAFLD). However, the precise mechanisms by which the ER stress response protects against NAFLD remain largely unknown. Recently, activin E has been linked to metabolic diseases such as insulin resistance and NAFLD. However, the physiological conditions and regulatory mechanisms driving hepatic\n                    <jats:italic>Inhbe<\/jats:italic>\n                    expression (which encodes activin E) as well as the metabolic role of activin E in NAFLD require further investigation. Here we found that hepatic\n                    <jats:italic>Inhbe<\/jats:italic>\n                    expression increased under prolonged fasting and ER stress conditions, which was mediated by ATF4, as determined by promoter analysis in a mouse model. Consistently, a positive correlation between\n                    <jats:italic>INHBE<\/jats:italic>\n                    and\n                    <jats:italic>ATF4<\/jats:italic>\n                    expression levels in relation to NAFLD status was confirmed using public human NAFLD datasets. To investigate the role of activin E in hepatic steatosis, we assessed the fluxes of the lipid metabolism in an\n                    <jats:italic>Inhbe<\/jats:italic>\n                    -knockout mouse model. These mice displayed a lean phenotype but developed severe hepatic steatosis under a high-fat diet. The deficiency of\n                    <jats:italic>Inhbe<\/jats:italic>\n                    resulted in increased lipolysis in adipose tissue, leading to increased fatty acid influx into the liver. Conversely, hepatic overexpression of\n                    <jats:italic>Inhbe<\/jats:italic>\n                    ameliorated hepatic steatosis by suppressing lipolysis in adipose tissue through ALK7\u2013Smad signaling. In conclusion, activin E serves as a regulatory hepatokine that prevents fatty acid influx into the liver, thereby protecting against NAFLD.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01403-6","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T04:53:38Z","timestamp":1739422418000},"page":"466-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue"],"prefix":"10.1038","volume":"57","author":[{"given":"Shi-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonil","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae-Mi","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Ho","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunhee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3464-6382","authenticated-orcid":false,"given":"Hui-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-2415","authenticated-orcid":false,"given":"Il-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"1403_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1403_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi, H. & Kaufman, R. J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 54, 795\u2013809 (2011).","journal-title":"J. Hepatol."},{"key":"1403_CR3","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","volume":"20","author":"XQ Zhang","year":"2014","unstructured":"Zhang, X. Q., Xu, C. F., Yu, C. H., Chen, W. X. & Li, Y. M. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 20, 1768\u20131776 (2014).","journal-title":"World J. Gastroenterol."},{"key":"1403_CR4","doi-asserted-by":"crossref","unstructured":"Horwath, J. A. et al. Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain. JCI Insight 10.1172\/jci.insight.90170 (2017).","DOI":"10.1172\/jci.insight.90170"},{"key":"1403_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin, C., Vall\u00e9e, D., Hazari, Y., Hetz, C., Chevet, E. & Bailly-Maitre, B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 69, 927\u2013947 (2018).","journal-title":"J. Hepatol."},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.2337\/db12-1397","volume":"62","author":"SMH Chan","year":"2013","unstructured":"Chan, S. M. H. et al. Activation of PPAR\u03b1 ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 62, 2095\u20132105 (2013).","journal-title":"Diabetes"},{"key":"1403_CR7","doi-asserted-by":"publisher","unstructured":"Namwanje, M. & Brown, C. W. Activins and inhibins: roles in development, physiology, and disease. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a021881 (2016).","DOI":"10.1101\/cshperspect.a021881"},{"key":"1403_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.lfs.2009.08.007","volume":"85","author":"O Hashimoto","year":"2009","unstructured":"Hashimoto, O., Sekiyama, K., Matsuo, T. & Hasegawa, Y. Implication of activin E in glucose metabolism: transcriptional regulation of the inhibin\/activin \u03b2E subunit gene in the liver. Life Sci. 85, 534\u2013540 (2009).","journal-title":"Life Sci."},{"key":"1403_CR9","doi-asserted-by":"crossref","unstructured":"Hashimoto, O. & Funaba, M. Activin in Glucose Metabolism 1st edn (Elsevier, 2011); 10.1016\/B978-0-12-385961-7.00011-1.","DOI":"10.1016\/B978-0-12-385961-7.00011-1"},{"key":"1403_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.metabol.2016.07.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Triantafyllou, G. & Mantzoros, C. S. Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metabolism 65, 1550\u20131558 (2016).","journal-title":"Metabolism"},{"key":"1403_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ijo.2012.28","volume":"37","author":"C Dani","year":"2013","unstructured":"Dani, C. Activins in adipogenesis and obesity. Int. J. Obes. 37, 163\u2013166 (2013).","journal-title":"Int. J. Obes."},{"key":"1403_CR12","doi-asserted-by":"publisher","first-page":"e0194798","DOI":"10.1371\/journal.pone.0194798","volume":"13","author":"M Sugiyama","year":"2018","unstructured":"Sugiyama, M. et al. Inhibin \u03b2E (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples. PLoS ONE 13, e0194798 (2018).","journal-title":"PLoS ONE"},{"key":"1403_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.taap.2012.08.011","volume":"264","author":"A Br\u00fcning","year":"2012","unstructured":"Br\u00fcning, A., Matsingou, C., Brem, G. J., Rahmeh, M. & Mylonas, I. Inhibin beta E is upregulated by drug-induced endoplasmic reticulum stress as a transcriptional target gene of ATF4. Toxicol. Appl. Pharmacol. 264, 300\u2013304 (2012).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1403_CR14","doi-asserted-by":"publisher","first-page":"16480","DOI":"10.1073\/pnas.0706794104","volume":"104","author":"SC Cheol","year":"2007","unstructured":"Cheol, S. C. et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc. Natl Acad. Sci. USA 104, 16480\u201316485 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1403_CR15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","volume":"56","author":"LP Bechmann","year":"2012","unstructured":"Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M. & Canbay, A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 56, 952\u2013964 (2012).","journal-title":"J. Hepatol."},{"key":"1403_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2016.124","volume":"12","author":"A Baiceanu","year":"2016","unstructured":"Baiceanu, A., Mesdom, P., Lagouge, M. & Foufelle, F. Endoplasmic reticulum proteostasis in hepatic steatosis. Nat. Rev. Endocrinol. 12, 710\u2013722 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1403_CR17","first-page":"333","volume":"18","author":"X Messeguer","year":"2002","unstructured":"Messeguer, X. et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinform. Appl. NOTE 18, 333\u2013334 (2002).","journal-title":"Bioinform. Appl. NOTE"},{"key":"1403_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00335-014-9520-4","volume":"25","author":"HY Lee","year":"2014","unstructured":"Lee, H. Y., Jeong, K. H. & Choi, C. S. In-depth metabolic phenotyping of genetically engineered mouse models in obesity and diabetes. Mamm. Genome 25, 508\u2013521 (2014).","journal-title":"Mamm. Genome"},{"key":"1403_CR19","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1073\/pnas.0800272105","volume":"105","author":"O Andersson","year":"2008","unstructured":"Andersson, O., Korach-Andre, M., Reissmann, E., Ib\u00e1\u00f1ez, C. F. & Bertolino, P. Growth\/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc. Natl Acad. Sci. USA 105, 7252\u20137256 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1403_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbrc.2009.03.014","volume":"382","author":"LMS Carlsson","year":"2009","unstructured":"Carlsson, L. M. S. et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem. Biophys. Res. Commun. 382, 309\u2013314 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1403_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2337\/db12-0295","volume":"62","author":"S Yogosawa","year":"2013","unstructured":"Yogosawa, S., Mizutani, S., Ogawa, Y. & Izumi, T. Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator\u2013activated receptor \u03b3 and C\/EBP\u03b1. Diabetes 62, 115\u2013123 (2013).","journal-title":"Diabetes"},{"key":"1403_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","volume":"26","author":"GF Cahill","year":"2006","unstructured":"Cahill, G. F. Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1\u201322 (2006).","journal-title":"Annu. Rev. Nutr."},{"key":"1403_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui, L. Energy metabolism in the liver. Compr. Physiol. 4, 177\u2013197 (2014).","journal-title":"Compr. Physiol."},{"key":"1403_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2023.101830","volume":"78","author":"JD Griffin","year":"2023","unstructured":"Griffin, J. D., Buxton, J. M., Culver, J. A., Barnes, R., Jordan, E. A. & White, A. R. Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acids. Mol Metab 78, 1\u201317 (2023).","journal-title":"Mol Metab"},{"key":"1403_CR25","doi-asserted-by":"crossref","unstructured":"Fougerat, A. et al. ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPAR\u03b1 activity. Cell Rep. 10.1016\/j.celrep.2022.110910 (2022).","DOI":"10.1101\/2021.01.28.428684"},{"key":"1403_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108633","volume":"95","author":"Z Yang","year":"2021","unstructured":"Yang, Z., Roth, K., Agarwal, M., Liu, W. & Petriello, M. C. The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. J. Nutr. Biochem. 95, 108633 (2021).","journal-title":"J. Nutr. Biochem."},{"key":"1403_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2018.10.008","volume":"25","author":"O Hashimoto","year":"2018","unstructured":"Hashimoto, O. et al. Activin E controls energy homeostasis in both brown and white adipose tissues as a hepatokine. Cell Rep. 25, 1193\u20131203 (2018).","journal-title":"Cell Rep."},{"key":"1403_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309967120","volume":"120","author":"RC Adam","year":"2023","unstructured":"Adam, R. C. et al. Activin E\u2013ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice. Proc. Natl Acad. Sci. USA 120, e3209967120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1403_CR29","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1111\/febs.16090","volume":"289","author":"CF Ib\u00e1\u00f1ez","year":"2022","unstructured":"Ib\u00e1\u00f1ez, C. F. Regulation of metabolic homeostasis by the TGF-\u03b2 superfamily receptor ALK7. FEBS J. 289, 5776\u20135797 (2022).","journal-title":"FEBS J."},{"key":"1403_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5551\/jat.54445","volume":"28","author":"WL Cheng","year":"2021","unstructured":"Cheng, W. L. et al. ALK7 acts as a positive regulator of macrophage activation through down-regulation of PPAR\u03b3 expression. J. Atheroscler. Thromb. 28, 375\u2013384 (2021).","journal-title":"J. Atheroscler. Thromb."},{"key":"1403_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.devcel.2019.04.015","volume":"49","author":"IP Michael","year":"2019","unstructured":"Michael, I. P. et al. ALK7 signaling manifests a homeostatic tissue barrier that is abrogated during tumorigenesis and metastasis. Dev. Cell 49, 409\u2013424.e6 (2019).","journal-title":"Dev. Cell"},{"key":"1403_CR32","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1038\/s41467-022-32398-7","volume":"13","author":"P Akbari","year":"2022","unstructured":"Akbari, P. et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat. Commun. 13, 4844 (2022).","journal-title":"Nat. Commun."},{"key":"1403_CR33","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1038\/s41467-022-31757-8","volume":"13","author":"AM Deaton","year":"2022","unstructured":"Deaton, A. M. et al. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity. Nat. Commun. 13, 4319 (2022).","journal-title":"Nat. Commun."},{"key":"1403_CR34","doi-asserted-by":"publisher","first-page":"e03245","DOI":"10.7554\/eLife.03245","volume":"3","author":"T Guo","year":"2014","unstructured":"Guo, T. et al. Adipocyte ALK7 links nutrient overload to catecholamine resistance in obesity. eLife 3, e03245 (2014).","journal-title":"eLife"},{"key":"1403_CR35","doi-asserted-by":"crossref","unstructured":"Bernard, D. J., Lee, K. B. & Santos, M. M. Activin B can signal through both ALK4 and ALK7 in gonadotrope cells. Reprod. Biol. Endocrinol. 10.1186\/1477-7827-4-52 (2006).","DOI":"10.1186\/1477-7827-4-52"},{"key":"1403_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.78197","volume":"11","author":"EJ Goebel","year":"2022","unstructured":"Goebel, E. J. et al. The orphan ligand, activin C, signals through activin receptor-like kinase 7. eLife 11, 1\u201320 (2022).","journal-title":"eLife"},{"key":"1403_CR37","doi-asserted-by":"crossref","unstructured":"Poursharifi, P. et al. Adipose ABHD6 regulates tolerance to cold and thermogenic programs. JCI Insight 10.1172\/jci.insight.140294 (2020).","DOI":"10.1172\/jci.insight.140294"},{"key":"1403_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tem.2009.06.002","volume":"20","author":"M Ahmadian","year":"2009","unstructured":"Ahmadian, M., Duncan, R. E. & Sul, H. S. The skinny on fat: lipolysis and fatty acid utilization in adipocytes. Trends Endocrinol. Metab. 20, 424\u2013428 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"1403_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen, E. D. & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847\u2013853 (2006).","journal-title":"Nature"},{"key":"1403_CR40","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1172\/JCI118363","volume":"96","author":"J Kopecky","year":"1995","unstructured":"Kopecky, J., Clarke, G., Enerb\u00e4ck, S., Spiegelman, B. & Kozak, L. P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J. Clin. Invest. 96, 2914\u20132923 (1995).","journal-title":"J. Clin. Invest."},{"key":"1403_CR41","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1073\/pnas.0308258100","volume":"101","author":"L Orci","year":"2004","unstructured":"Orci, L. et al. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc. Natl Acad. Sci. USA 101, 2058\u20132063 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1403_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cmet.2006.02.001","volume":"3","author":"T Yamada","year":"2006","unstructured":"Yamada, T. et al. Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab. 3, 223\u2013229 (2006).","journal-title":"Cell Metab."},{"key":"1403_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1003118","volume":"10","author":"E B\u00f6rgeson","year":"2022","unstructured":"B\u00f6rgeson, E., Boucher, J. & Hagberg, C. E. Of mice and men: pinpointing species differences in adipose tissue biology. Front. Cell Dev. Biol. 10, 1003118 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1403_CR44","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","volume":"14","author":"SM Gordon","year":"2015","unstructured":"Gordon, S. M., Li, H., Zhu, X., Shah, A. S., Lu, L. J. & Davidson, W. S. A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins. J. Proteome Res. 14, 2686\u20132695 (2015).","journal-title":"J. Proteome Res."},{"key":"1403_CR45","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1194\/jlr.R800053-JLR200","volume":"50","author":"CA Nagle","year":"2009","unstructured":"Nagle, C. A., Klett, E. L. & Coleman, R. A. Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 50, S74\u2013S79 (2009).","journal-title":"J. Lipid Res."},{"key":"1403_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/db15-0941","volume":"65","author":"S Wueest","year":"2016","unstructured":"Wueest, S. et al. Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance. Diabetes 65, 140\u2013148 (2016).","journal-title":"Diabetes"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01403-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T10:07:40Z","timestamp":1740996460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01403-6","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.-Y.K. and S.P. are shareholders in Myocare, Inc. The other authors have no conflicts of interest to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}